Anti-B7-H1/PD-L1/CD274 Antibody (Sugemalimab)
Catalog No.
F1320
Anti-B7-H1/PD-L1/CD274 Antibody (Sugemalimab)
Featured Products
Sugemalimab is a fully human, full-length anti-programmed death-ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab has shown anticancer activity and can be used in the study of non-small cell lung cancer.
145 kDa
Dry ice
2256084-03-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
EQ165, CS-1001
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NZQ7
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-B7-H1/PD-L1/CD274 Antibody (Sugemalimab) is more than 95%, determined by SEC-HPLC.
B7-H1 / PD-L1 / CD274
Please avoid freeze-thaw cycles.